Toll Free: 1-888-928-9744

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 188 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, 
 Table of Contents
1 Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Deep Vein Thrombosis (DVT) 31 Mar 23, 2016: Boehringer Ingelheim launches RE-COVERY DVT/PE: global observational study on management of Deep Vein Thrombosis and Pulmonary Embolism with Pradaxa (dabigatran etexilate) 31 Clinical Trial Profile Snapshots 32 Appendix 185 Abbreviations 185 Definitions 185 Research Methodology 186 Secondary Research 186 About GlobalData 187 Contact Us 187 Disclaimer 187 Source 188
List of Tables
Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Deep Vein Thrombosis (DVT) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Deep Vein Thrombosis (DVT) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Deep Vein Thrombosis (DVT) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Deep Vein Thrombosis (DVT) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Deep Vein Thrombosis (DVT) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Deep Vein Thrombosis (DVT) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Deep Vein Thrombosis (DVT) to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Deep Vein Thrombosis (DVT) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Deep Vein Thrombosis (DVT) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Deep Vein Thrombosis (DVT) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Deep Vein Thrombosis (DVT) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Deep Vein Thrombosis (DVT) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 186

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to dri

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify